… immunomodulatory therapies as adjunctive treatments.3 This systematic review focuses on
immunomodulatory agents other … non-corticosteroid immunomodulatory therapy adjunctive to …

… Figure 2 Pooled analysis of the frequency of serious adverse events in treatment groups …
reported in randomised controlled trials of different categories of immunomodulatory drugs. (a) …

… After the publication of the protocol but prior to data analysis, … use of a systemic
immunomodulatory agent, or when results … evaluated 20 different systemic immunomodulatory …

… , mitoxantrone appeared to be the most effective agent in … meta‐analysis revealed that
none of the individual agents … network formed of agents administered at different doses (so …

… The key treatments during this stage are immunomodulatory agents, most of which are … to
other immunomodulators. Our findings were consistent with those of a previous meta-analysis […

… independent two‐arm studies in pairwise meta‐analysis; we accounted for the correlation …
in network meta‐analysis. We converted multi‐arm trials involving the same agent at different …

… Systemic immunomodulatory agents used to … different itch numeric rating scales if they
assessed worst or peak (as opposed to average) itch. In separate analyses, we combined different …

… We ran the analyses repeatedly, removing one different study for each iteration to observe
the change of pooled hazard ratios. The pooled hazard ratios ranged from 0.61 to 0.63 for …

… This systematic review and meta-analysis aim to assess the efficacy of different
immunomodulatory … Previous treatments with other immunosuppressive or immunomodulatory …

… thought to their routine use in treating pneumonia.6, 7, 8, 9 Corticosteroids, non-steroidal
anti-inflammatory agents and glitazones are other commonly used drugs with well described …